









Markets
/
Stocks
/
nasdaq-gehc
/

GE Healthcare Technologies Inc

GEHC

72.610USD

+0.960+1.34%

Market hours （ET）Quotes delayed by 15 min

33.02BMarket Cap

15.89P/E TTM



GE Healthcare Technologies Inc

72.610

+0.960+1.34%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of GE Healthcare Technologies Inc

Currency: USD Updated: 2026-03-24

Key Insights

GE Healthcare Technologies Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 33 out of 209 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 93.12.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

GE Healthcare Technologies Inc's Score

Industry at a Glance

Industry Ranking

33 / 209

Overall Ranking

115 / 4547

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive+

GE Healthcare Technologies Inc Highlights

StrengthsRisks

GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 20.62B.

Undervalued

The company’s latest PE is 15.53, at a low 3-year percentile range.

Held by Nelson Peltz

Star Investor Nelson Peltz holds 4.04K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.10.

Analyst Rating

Based on 22 analysts

Buy

Current Rating

93.117

Target Price

+33.69%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-24

The current financial score of GE Healthcare Technologies Inc is 8.67, ranking 21 out of 209 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 5.70B, representing a year-over-year increase of 7.13%, while its net profit experienced a year-over-year increase of 18.31%.

Score

Industry at a Glance

Previous score

8.67

Change



Financials

6.70

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.80

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

8.47

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

9.76

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

9.63

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

GE Healthcare Technologies Inc's Company Valuation

Currency: USD Updated: 2026-03-24

The current valuation score of GE Healthcare Technologies Inc is 6.12, ranking 170 out of 209 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 15.53, which is 98.61% below the recent high of 30.84 and 20.92% above the recent low of 12.28.

Score

Industry at a Glance

Previous score

6.12

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 33/209

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-24

The current earnings forecast score of GE Healthcare Technologies Inc is 7.73, ranking 122 out of 209 in the Healthcare Equipment & Supplies industry. The average price target is 88.00, with a high of 108.00 and a low of 73.00.

Score

Industry at a Glance

Previous score

7.73

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 22 analysts

Buy

Current Rating

93.117

Target Price

+33.69%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

GE Healthcare Technologies Inc

GEHC

Boston Scientific Corp

BSX

Intuitive Surgical Inc

ISRG

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-24

The current price momentum score of GE Healthcare Technologies Inc is 6.76, ranking 87 out of 209 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 80.95 and the support level at 64.99, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.89

Change

-0.13

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(2)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.433

Sell

RSI(14)

36.264

Neutral

STOCH(KDJ)(9,3,3)

37.267

Buy

ATR(14)

2.337

Low Volatility

CCI(14)

-46.285

Neutral

Williams %R

79.071

Sell

TRIX(12,20)

-0.607

Sell

StochRSI(14)

80.831

Buy

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

70.578

Buy

MA10

71.115

Buy

MA20

75.021

Sell

MA50

78.830

Sell

MA100

79.381

Sell

MA200

76.899

Sell

Institutional Confidence

Currency: USD Updated: 2026-03-24

The current institutional shareholding score of GE Healthcare Technologies Inc is 7.00, ranking 81 out of 209 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 85.71%, representing a quarter-over-quarter decrease of 0.42%. The largest institutional shareholder is The Vanguard, holding a total of 52.06M shares, representing 11.42% of shares outstanding, with 2.15% increase in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

51.80M

-0.20%

Dodge & Cox

Star Investors

27.52M

+16.76%

Capital Research Global Investors

24.97M

+25.02%

BlackRock Institutional Trust Company, N.A.

24.66M

+0.13%

State Street Investment Management (US)

19.65M

-0.07%

Harris Associates L.P.

Star Investors

11.02M

+13.95%

Geode Capital Management, L.L.C.

12.08M

+1.10%

Invesco Capital Management (QQQ Trust)

10.22M

+6.78%

Hotchkis and Wiley Capital Management, LLC

Star Investors

8.43M

+17.12%

Norges Bank Investment Management (NBIM)

6.32M

+1.14%

Risk Assessment

Currency: USD Updated: 2026-03-24

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of GE Healthcare Technologies Inc is 8.69, ranking 21 out of 209 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.